HAIKOU, China, Nov. 12, 2018 /PRNewswire/ --
China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an
NYSE MKT listed corporation with its fully-integrated specialty
pharmaceuticals subsidiary based in China, today announced that it plans to hold
its third quarter 2018 earnings conference call on Thursday, November 15, 2018 at 8:30 a.m. ET.
Listeners may access the call by dialing 1-866-519-4004 or
65-671-350-90 for international callers, Conference ID #
4389333. A replay of the call will be accessible through
November 23, 2018 by dialing
1-855-452-5696 or 61-281-990-299 for international callers,
Conference ID # 4389333.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical
company that develops, manufactures and markets a diversified
portfolio of products focused on conditions with a high incidence
and high mortality rates in China,
including cardiovascular, CNS, infectious, and digestive diseases.
The Company's cost-effective business model is driven by market
demand and supported by new GMP-certified product lines covering
the major dosage forms. In addition, the Company has a broad and
expanding nationwide distribution network across all major cities
and provinces in China. The
Company's wholly-owned subsidiary, Hainan Helpson Medical &
Biotechnology Co., Ltd., is located in Haikou City, Hainan
Province. For more information about China Pharma Holdings,
Inc., please visit http://www.chinapharmaholdings.com. The Company
routinely posts important information on its website.
View original
content:http://www.prnewswire.com/news-releases/cphi-to-hold-third-quarter-2018-earnings-conference-call-on-thursday-november-15-2018-at-830-am-et-300748134.html
SOURCE China Pharma Holdings, Inc.